Evidence map›Paper›PMID 31267172›Full record

ArticleMedical microbiology and immunology2019

Interplay between IDO1 and iNOS in human retinal pigment epithelial cells.

Katrin Spekker-Bosker, Christoph-Martin Ufermann, Maike Oldenburg, Walter Däubener, Silvia Kathrin Eller

Open access · hybridAbstract read
In one paragraph

Article in Medical microbiology and immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Interleukin-17-mediated protective cytokine signaling against degeneration of the retinal pigment epithelium.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katrin Spekker-BoskerInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, Bldg. 22.21, 40225, Düsseldorf, Germany.
Christoph-Martin UfermannInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, Bldg. 22.21, 40225, Düsseldorf, Germany.
Maike OldenburgInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, Bldg. 22.21, 40225, Düsseldorf, Germany.
Walter DäubenerInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, Bldg. 22.21, 40225, Düsseldorf, Germany.
Silvia Kathrin EllerInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, Bldg. 22.21, 40225, Düsseldorf, Germany. silvia.eller@uni-duesseldorf.de.ORCID http://orcid.org/0000-0002-4106-3695
Heinrich Heine University Düsseldorf · DE

Funding

Jürgen Manchot Stiftung Molecules of Infection III
6 · The paper itself

Abstract

Human retinal pigment epithelial (hRPE) cells form a selectively permeable monolayer between the neural retina and the highly permeable choroidal vessels. Thus, hRPE cells bear important regulatory functions and are potential targets of pathogens in vivo. Endogenous bacterial endophthalmitis (EBE) is frequently caused by infections with the Gram-positive bacterium Staphylococcus aureus (S. aureus). Upon microbial infection, interferon gamma (IFN-γ), a major cytokine of the adaptive immune response, induces a broad spectrum of effector molecules, such as the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase-1 (IDO1). We stimulated human RPE (hRPE) cells in vitro with proinflammatory cytokines and analyzed the expression levels and enzymatic activities of IDO1 and inducible nitric oxide synthase (iNOS), another antimicrobial effector molecule. The antimicrobial capacity was analyzed in infection experiments using S. aureus and Toxoplasma gondii (T. gondii). Our aim was to characterize the particular importance of IDO1 and iNOS during EBE. We found that an IFN-γ stimulation of hPRE cells induced the expression of IDO1, which inhibited the growth of T. gondii and S. aureus. A co-stimulation with IFN-γ, interleukin-1 beta, and tumor necrosis factor alpha induced a strong expression of iNOS. The iNOS-derived nitric oxide production was dependent on cell-culture conditions; however, it could not cause antimicrobial effects. iNOS did not act synergistically with IDO1. Instead, iNOS activity inhibited IDO1-mediated tryptophan degradation and bacteriostasis. This effect was reversible by the addition of the iNOS inhibitor N

Indexed as

Cell LineEndophthalmitisEpithelial CellsHumansImmunologic FactorsIndoleamine-Pyrrole 2,3,-DioxygenaseModels, TheoreticalNitric Oxide Synthase Type IIRetinal Pigment EpitheliumStaphylococcus aureusToxoplasmaIDO1 protein, humanImmunologic FactorsIndoleamine-Pyrrole 2,3,-DioxygenaseNitric Oxide Synthase Type IINOS2 protein, humanEndogenous bacterial endophthalmitisIDO1Indoleamine 2,3-dioxygenase-1Inducible nitric oxide synthaseiNOSRetinal pigment epithelial cellsStaphylococcus aureusToxoplasma gondii

Identifiers

PMID31267172
PMCPMC6817751
OpenAlexW2955255767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.